Navigation Links
The Centers For Medicare and Medicaid Services Issues Advance Guidance to Part D Plan Sponsors Allowing the Use of Generic Sampling as Medicare Part D Drug Utilization Management Tool.
Date:3/10/2011

SAN DIEGO, March 10, 2011 /PRNewswire/ -- MedVantx, Inc., the company that created first ever controlled access to generic samples in US physician offices, today announced that the Centers For Medicare and Medicaid Services ("CMS") has issued preliminary guidance to Medicare Part D Plan Sponsors on generic sampling programs. In a February 11, 2011 advanced notice for public comment, CMS indicated that a Part D sponsor may incur expenses related to distribution of and reporting on generic drug samples, provided to members within a physician's office setting, under the plan's administrative cost structure.  Once this proposal is finalized, Part D plan sponsors may account for MedVantx's generic sampling program both in their 2012 Medicare offering and in the current year.

MedVantx provides free generic medications in US physician offices for consumers through its proprietary automated ATM-like prescription management system (MedStart™). The MedStart™ system automates the traditional pharmaceutical sampling process for the physician and the MedVantx Patient ProfileLink™ interface captures physician sampling data in the patient's health plan electronic medical record claims history. Through the MedVantx program, patients managing complex and chronic conditions can receive generic samples covering the majority of acute and chronic conditions as part of their physician office visit. MedVantx collaborates with physicians and health plans to provide consumers access to integrated care coordination management and reimbursement counseling services and the convenience of home delivery of low cost prescriptions.  The program has proven effective in reducing costs and critical gaps in care for patients with chronic and complex diseases.

"We are excited about the use of the MedVantx ProfileLink™ claims data in the Medicare Part D marketplace," said Susan Hogue, RPh, and MedVantx Director of Managed Networks & Clinical Services. "As the US prescription drug marketplace continues its rapid shift to low cost generics and consumerism, the ability to capture claims data on generic sample utilization at the point of care will help insure the clinical integrity of a Part D plan sponsor's pharmacy database."

In the advance notice, CMS also recognized that generic sampling could be an effective tool to promote compliance with drug therapy and lower costs for Medicare and reduce beneficiary copayments.  "By facilitating access to trial supplies of less costly generic versions of Part D drugs, plan sponsors can enhance their enrollees experience in Part D by reducing their current and future cost sharing expenses.  In the case of low income beneficiaries, facilitating medication starts on generic versions of drugs also helps to limit federal low income costs sharing subsidy requirements and overall program costs for the Medicare Trust Fund."  

"Traditional pharmaceutical cost management approaches have been maximized and Part D plan sponsors are seeking new tools to engage and influence physician and consumer behavior at the point of care," stated Robert Feeney, Chief Executive Officer of MedVantx. "The MedVantx physician network has helped over 2M patients start on generic therapy at the point of care and we are excited about the potential use of the MedVantx platform in the Part D marketplace," added Mr. Feeney.

Information regarding the Advanced Notification Guidance from The Centers For Medicare and Medicaid Services web site at www.cms.gov/PrescriptionDrugCovContra/Downloads/2011CombinedCallLetter.pdfAbout MedVantx, Inc.MedVantx is an innovative consumer medication management and delivery company committed to streamlining access, reducing costs and providing highly relevant information to benefit patients, physicians, health plans and manufacturers.  The MedVantx platform is a fully automated / integrated point of care to consumer home delivery channel focused on increasing the quality and cost effectiveness of the last non-managed pharmaceutical channel - the physician's office sample closet.  The Company's consumer medication management platform includes free initial prescription and over-the-counter medication therapy at the point of care; a consumer helpline providing drug information and reimbursement assistance and convenient consumer home delivery through its mail order pharmacy. The national MedVantx network has served over 2 million consumers through an integrated network including 16 health plans, 18 manufacturers and more than 3,600 prescribers.

For additional information about MedVantx and opportunities to participate in MedVantx Network, please contact MedVantx, Inc. at (858) 625-2990.MedVantx Contact:Susan Hogue(858) 625-2990 Ext. 142susan.hogue@medvantx.com
'/>"/>

SOURCE MedVantx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Anesthesiologists Use Caldolor® To Provide Preemptive Pain Control for Surgical Patients at U.S. Medical Centers
2. Papastavros Opens New Radiology Centers in Delaware
3. Astrum Hearing Inc. Is Not Affiliated with Astrum Hearing Aid Centers or Astrum Marketing
4. CyberKnife Centers of Miami and Palm Beach Announce New Chief Operating Officer
5. Cancer Treatment Centers Oncology Information System Options Expand with New MOSAIQ Connectivity
6. NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
7. Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
8. Seven U.S. Medical Centers Commence Study to Change Femoral Artery Cath Lab Access with the First Alternative to the Seldinger Technique in 51 Years
9. CURE Foundation Selects Varian Medical Systems to Supply Radiotherapy Technology for Five New Cancer Centers
10. Fenwal Named Exclusive Provider of AccuVeins Award-Winning Vein Illumination Device for Blood and Plasma Centers
11. Prenatal Imaging Centers, LLC Finds the 3D/4D Keepsake Exam an Opportunity to Screen Pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... , Feb. 17, 2017   FormFast , ... announced a new partnership with Engage , one ... United States . FormFast will serve as the ... Engage,s implementations with MEDITECH .  ... essential functionality to complement and enhance the electronic health ...
(Date:2/17/2017)...  BioDigital, Inc., creators of the BioDigital Human ... body mapping technology with eClinicalWorks, a privately held ... be used to capture and present dermatology exam ... body. BioDigital pilots show using a body to ... the precision of clinical annotations compared to standard ...
(Date:2/17/2017)... YORK , Feb. 17, 2017  Noble Capital ... on ESSA Pharma Inc. (Nasdaq: EPIX ). ... Research, Kumar Raja , PhD. ESSA ... for castration resistant prostate cancer (CRPC). Its lead compound ... blocks the amino-terminal domain of the androgen receptor, thereby ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... February 20, 2017 , ... ... self-service technology that runs on the Posiflex XT-series of touch screen terminals. Both ... HIMSS17 in Orlando, Florida. The terminal provider Posiflex is helping to bridge ...
(Date:2/20/2017)... , ... February 20, 2017 , ... ... welcomes you to stop by for a visit this week at HIMSS 2017 ... and executives from around the globe. Sensogram will be featured in the conference’s ...
(Date:2/20/2017)... Houston, TX (PRWEB) , ... February 20, 2017 ... ... he is now offering a full range of emergency dental care at his ... teeth and gums. When patients experience dental emergencies, they are at risk for ...
(Date:2/20/2017)... Orlando, FL (PRWEB) , ... February 20, 2017 ... ... company for eye care providers and health plan partners, announced during the 2017 ... the organization’s success enhancing care coordination for diabetic patients and integrating eye ...
(Date:2/19/2017)... (PRWEB) , ... February 19, 2017 , ... Braun Industries ... JEMS Conference & Exposition, the event will take place February 23-25, 2017 at the ... will be in Booth #909 with three new ambulances on display. ...
Breaking Medicine News(10 mins):